Cadrenal Therapeutics Files 8-K
Ticker: CVKD · Form: 8-K · Filed: Apr 17, 2025 · CIK: 1937993
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: CADR
TL;DR
CADR filed an 8-K, but details are scarce in this snippet.
AI Summary
Cadrenal Therapeutics, Inc. filed an 8-K on April 17, 2025, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or any financial figures within the provided text.
Why It Matters
This 8-K filing indicates that Cadrenal Therapeutics, Inc. has made a regulatory submission, but the specific details of the events or financial information are not immediately available in this excerpt.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for Cadrenal Therapeutics, Inc. and the provided text does not contain information that suggests immediate or significant risk.
Key Players & Entities
- Cadrenal Therapeutics, Inc. (company) — Registrant
- April 17, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-41596 (identifier) — SEC File Number
- 88-0860746 (identifier) — IRS Employer Identification No.
- 822 A1A North , Suite 306 Ponte Vedra , Florida 32082 (address) — Principal executive offices
- 904-300-0701 (phone_number) — Registrant's telephone number
FAQ
What specific events are being reported in this 8-K filing by Cadrenal Therapeutics, Inc.?
The provided text for the 8-K filing by Cadrenal Therapeutics, Inc. on April 17, 2025, indicates 'Other Events' and 'Financial Statements and Exhibits' as items, but does not specify the details of these events.
What is the principal executive office address for Cadrenal Therapeutics, Inc.?
The principal executive offices for Cadrenal Therapeutics, Inc. are located at 822 A1A North, Suite 306, Ponte Vedra, Florida 32082.
What is the SEC file number for Cadrenal Therapeutics, Inc.?
The SEC file number for Cadrenal Therapeutics, Inc. is 001-41596.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing by Cadrenal Therapeutics, Inc. is dated April 17, 2025.
What is the IRS Employer Identification Number for Cadrenal Therapeutics, Inc.?
The IRS Employer Identification Number for Cadrenal Therapeutics, Inc. is 88-0860746.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2025 regarding Cadrenal Therapeutics, Inc. (CVKD).